Clinical Trial Update: Reduced Intensity Transplant Using Extracorporeal Photopheresis [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 1/2 study evaluating reduced-intensity transplant using extracorporeal photopheresis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Leukemia

Snippet

Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago | Conditions: Leukemia, Cancer | Phase 1, Phase 2 | Status: COMPLETED